{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T05:22:54Z","timestamp":1768972974476,"version":"3.49.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T00:00:00Z","timestamp":1682985600000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Can J Anesth\/J Can Anesth"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s12630-023-02415-4","type":"journal-article","created":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T19:03:04Z","timestamp":1683054184000},"page":"713-723","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Potential pharmacological confounders in the setting of death determined by neurologic criteria: a narrative review","Facteurs confondants pharmacologiques potentiels dans le contexte d\u2019une d\u00e9termination de d\u00e9c\u00e8s selon des crit\u00e8res neurologiques : un compte rendu narratif"],"prefix":"10.1007","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0594-0360","authenticated-orcid":false,"given":"Salmaan","family":"Kanji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Hartwick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,2]]},"reference":[{"key":"2415_CR1","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1001\/jama.2020.11586","volume":"324","author":"DM Greer","year":"2020","unstructured":"Greer DM, Shemie SD, Lewis A, et al. Determination of brain death\/death by neurologic criteria: the World Brain Death Project. JAMA 2020; 324: 1078\u201397. https:\/\/doi.org\/10.1001\/jama.2020.11586","journal-title":"JAMA"},{"key":"2415_CR2","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1001\/jama.2020.11665","volume":"324","author":"RD Truog","year":"2020","unstructured":"Truog RD, Krishnamurthy K, Tasker RC. Brain Death-moving beyond consistency in the diagnostic criteria. JAMA 2020; 324: 1045\u20137. https:\/\/doi.org\/10.1001\/jama.2020.11665","journal-title":"JAMA"},{"key":"2415_CR3","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1007\/s00134-014-3242-7","volume":"40","author":"SD Shemie","year":"2014","unstructured":"Shemie SD, Hornby L, Baker A, et al. International guideline development for the determination of death. Intensive Care Med 2014; 40: 788\u201397. https:\/\/doi.org\/10.1007\/s00134-014-3242-7","journal-title":"Intensive Care Med"},{"key":"2415_CR4","doi-asserted-by":"publisher","unstructured":"Wijdicks EF, Varelas PN, Gronseth GS, Greer DM, American Academy of Neurology. Evidence-based guideline update: determining brain death in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2010; 74: 1911\u20138. https:\/\/doi.org\/10.1212\/wnl.0b013e3181e242a8","DOI":"10.1212\/wnl.0b013e3181e242a8"},{"key":"2415_CR5","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jcrc.2019.06.030","volume":"53","author":"P Grzonka","year":"2019","unstructured":"Grzonka P, Tisljar K, R\u00fcegg S, Marsch S, Sutter R. What to exclude when brain death is suspected. J Crit Care 2019; 53: 212\u20137. https:\/\/doi.org\/10.1016\/j.jcrc.2019.06.030","journal-title":"J Crit Care"},{"key":"2415_CR6","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1007\/s12028-020-01114-y","volume":"34","author":"L Murphy","year":"2021","unstructured":"Murphy L, Wolfer H, Hendrickson RG. Toxicologic confounders of brain death determination: a narrative review. Neurocrit Care 2021; 34: 1072\u201389. https:\/\/doi.org\/10.1007\/s12028-020-01114-y","journal-title":"Neurocrit Care"},{"key":"2415_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.bcp.2013.09.007","volume":"87","author":"J Fan","year":"2014","unstructured":"Fan J, de Lannoy IA. Pharmacokinetics. Biochem Pharmacol 2014; 87: 93\u2013120. https:\/\/doi.org\/10.1016\/j.bcp.2013.09.007","journal-title":"Biochem Pharmacol"},{"key":"2415_CR8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2165\/00003088-199835030-00004","volume":"35","author":"BA Boucher","year":"1998","unstructured":"Boucher BA, Hanes SD. Pharmacokinetic alterations after severe head injury. Clinical relevance. Clin Pharmacokinet 1998; 35: 209\u201321. https:\/\/doi.org\/10.2165\/00003088-199835030-00004","journal-title":"Clinical relevance. Clin Pharmacokinet"},{"key":"2415_CR9","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.ccc.2006.02.011","volume":"22","author":"BA Boucher","year":"2006","unstructured":"Boucher BA, Wood GC, Swanson JM. Pharmacokinetic changes in critical illness. Crit Care Clin 2006; 22: 255\u201371. https:\/\/doi.org\/10.1016\/j.ccc.2006.02.011","journal-title":"Crit Care Clin"},{"key":"2415_CR10","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1378\/chest.11-1396","volume":"141","author":"BS Smith","year":"2012","unstructured":"Smith BS, Yogaratnam D, Levasseur-Franklin KE, Forni A, Fong J. Introduction to drug pharmacokinetics in the critically ill patient. Chest 2012; 141: 1327\u201336. https:\/\/doi.org\/10.1378\/chest.11-1396","journal-title":"Chest"},{"key":"2415_CR11","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jchromb.2012.07.005","volume":"903","author":"S Ghassabian","year":"2012","unstructured":"Ghassabian S, Moosavi SM, Valero YG, Shekar K, Fraser JF, Smith MT. High-throughput assay for simultaneous quantification of the plasma concentrations of morphine, fentanyl, midazolam and their major metabolites using automated SPE coupled to LC-MS\/MS. J Chromatogr B Analyt Technol Biomed Life Sci 2012; 903: 126\u201333. https:\/\/doi.org\/10.1016\/j.jchromb.2012.07.005","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"2415_CR12","doi-asserted-by":"publisher","unstructured":"Jutras M, Williamson D, Chass\u00e9 M, Leclair G. Development and validation of a liquid chromatography coupled to tandem mass spectrometry method for the simultaneous quantification of five analgesics and sedatives, and six of their active metabolites in human plasma: application to a clinical study on the determination of neurological death in the intensive care unit. J Pharm Biomed Anal 2020; 190: 113521. https:\/\/doi.org\/10.1016\/j.jpba.2020.113521","DOI":"10.1016\/j.jpba.2020.113521"},{"key":"2415_CR13","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1093\/jat\/30.3.196","volume":"30","author":"A Meinitzer","year":"2006","unstructured":"Meinitzer A, M\u00e4rz W, Mangge H, Halwachs-Baumann G. More reliable brain death diagnosis with chromatographic analysis of midazolam, diazepam, thiopentone, and active metabolites. J Anal Toxicol 2006; 30: 196\u2013201. https:\/\/doi.org\/10.1093\/jat\/30.3.196","journal-title":"J Anal Toxicol"},{"key":"2415_CR14","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1097\/ccm.0000000000002027","volume":"44","author":"MJ Murray","year":"2016","unstructured":"Murray MJ, DeBlock H, Erstad B, et al. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med 2016; 44: 2079\u2013103. https:\/\/doi.org\/10.1097\/ccm.0000000000002027","journal-title":"Crit Care Med"},{"key":"2415_CR15","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1016\/j.jpainsymman.2005.01.007","volume":"29","author":"A Murray","year":"2005","unstructured":"Murray A, Hagen NA. Hydromorphone. J Pain Symptom Manage 2005; 29: S57\u201366. https:\/\/doi.org\/10.1016\/j.jpainsymman.2005.01.007","journal-title":"J Pain Symptom Manage"},{"key":"2415_CR16","first-page":"149","volume":"42","author":"JJ Driessen","year":"1991","unstructured":"Driessen JJ, Vree TB, Guelen PJ. The effects of acute changes in renal function on the pharmacokinetics of midazolam during long-term infusion in ICU patients. Acta Anaesthesiol Belg 1991; 42: 149\u201355.","journal-title":"Acta Anaesthesiol Belg"},{"key":"2415_CR17","doi-asserted-by":"publisher","unstructured":"Swart EL, de Jongh J, Zuideveld KP, Danhof M, Thijs LG, Strack van Schijndel RJ. Population pharmacokinetics of lorazepam and midazolam and their metabolites in intensive care patients on continuous venovenous hemofiltration. Am J Kidney Dis 2005; 45: 360\u201371. https:\/\/doi.org\/10.1053\/j.ajkd.2004.09.004","DOI":"10.1053\/j.ajkd.2004.09.004"},{"key":"2415_CR18","doi-asserted-by":"publisher","first-page":"517","DOI":"10.5414\/cpp43517","volume":"43","author":"A Meinitzer","year":"2005","unstructured":"Meinitzer A, Zink M, M\u00e4rz W, Baumgartner A, Halwachs-Baumann G. Midazolam and its metabolites in brain death diagnosis. Int J Clin Pharmacol Ther 2005; 43: 517\u201326. https:\/\/doi.org\/10.5414\/cpp43517","journal-title":"Int J Clin Pharmacol Ther"},{"key":"2415_CR19","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10928-019-09626-7","volume":"46","author":"LZ Benet","year":"2019","unstructured":"Benet LZ, Bowman CM, Koleske ML, Rinaldi CL, Sodhi JK. Understanding drug-drug interaction and pharmacogenomic changes in pharmacokinetics for metabolized drugs. J Pharmacokinet Pharmacodyn 2019; 46: 155\u201363. https:\/\/doi.org\/10.1007\/s10928-019-09626-7","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"2415_CR20","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1177\/0310057x0503300306","volume":"33","author":"EJ Murphy","year":"2005","unstructured":"Murphy EJ. Acute pain management pharmacology for the patient with concurrent renal or hepatic disease. Anaesth Intensive Care 2005; 33: 311\u201322. https:\/\/doi.org\/10.1177\/0310057x0503300306","journal-title":"Anaesth Intensive Care"},{"key":"2415_CR21","doi-asserted-by":"publisher","unstructured":"Soleimanpour H, Safari S, Shahsavari Nia K, Sanaie S, Alavian SM. Opioid drugs in patients with liver disease: a systematic review. Hepat Mon 2016; 16: e32636. https:\/\/doi.org\/10.5812\/hepatmon.32636","DOI":"10.5812\/hepatmon.32636"},{"key":"2415_CR22","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.amjopharm.2004.12.005","volume":"2","author":"BJ Cusack","year":"2004","unstructured":"Cusack BJ. Pharmacokinetics in older persons. Am J Geriatr Pharmacother 2004; 2: 274\u2013302. https:\/\/doi.org\/10.1016\/j.amjopharm.2004.12.005","journal-title":"Am J Geriatr Pharmacother"},{"key":"2415_CR23","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/clpt.2008.64","volume":"84","author":"A Liukas","year":"2008","unstructured":"Liukas A, Kuusniemi K, Aantaa R, et al. Plasma concentrations of oral oxycodone are greatly increased in the elderly. Clin Pharmacol Ther 2008; 84: 462\u20137. https:\/\/doi.org\/10.1038\/clpt.2008.64","journal-title":"Clin Pharmacol Ther"},{"key":"2415_CR24","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.cger.2016.06.006","volume":"32","author":"JG Naples","year":"2016","unstructured":"Naples JG, Gellad WF, Hanlon JT. The role of opioid analgesics in geriatric pain management. Clin Geriatr Med 2016; 32: 725\u201335. https:\/\/doi.org\/10.1016\/j.cger.2016.06.006","journal-title":"Clin Geriatr Med"},{"key":"2415_CR25","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1093\/ageing\/afab003","volume":"50","author":"SN Hilmer","year":"2021","unstructured":"Hilmer SN, Kirkpatrick CM. New horizons in the impact of frailty on pharmacokinetics: latest developments. Age Ageing 2021; 50: 1054\u201363. https:\/\/doi.org\/10.1093\/ageing\/afab003","journal-title":"Age Ageing"},{"key":"2415_CR26","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s13054-020-03040-z","volume":"24","author":"BL Erstad","year":"2020","unstructured":"Erstad BL, Barletta JF. Drug dosing in the critically ill obese patient-a focus on sedation, analgesia, and delirium. Crit Care 2020; 24: 315. https:\/\/doi.org\/10.1186\/s13054-020-03040-z","journal-title":"Crit Care"},{"key":"2415_CR27","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s40262-014-0166-x","volume":"53","author":"MJ Brill","year":"2014","unstructured":"Brill MJ, van Rongen A, Houwink AP, et al. Midazolam pharmacokinetics in morbidly obese patients following semi-simultaneous oral and intravenous administration: a comparison with healthy volunteers. Clin Pharmacokinet 2014; 53: 931\u201341. https:\/\/doi.org\/10.1007\/s40262-014-0166-x","journal-title":"Clin Pharmacokinet"},{"key":"2415_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/00000542-198461010-00006","volume":"61","author":"DJ Greenblatt","year":"1984","unstructured":"Greenblatt DJ, Abernethy DR, Locniskar A, Harmatz JS, Limjuco RA, Shader RI. Effect of age, gender, and obesity on midazolam kinetics. Anesthesiology 1984; 61: 27\u201335.","journal-title":"Anesthesiology"},{"key":"2415_CR29","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13054-022-03941-1","volume":"26","author":"JF Barletta","year":"2022","unstructured":"Barletta JF, Erstad BL. Drug dosing in hospitalized obese patients with COVID-19. Crit Care 2022; 26: 60. https:\/\/doi.org\/10.1186\/s13054-022-03941-1","journal-title":"Crit Care"},{"key":"2415_CR30","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s40262-018-0636-7","volume":"57","author":"I Bilbao-Meseguer","year":"2018","unstructured":"Bilbao-Meseguer I, Rodr\u00edguez-Gasc\u00f3n A, Barrasa H, Isla A, Solin\u00eds M\u00c1. Augmented renal clearance in critically ill patients: a systematic review. Clin Pharmacokinet 2018; 57: 1107\u201321. https:\/\/doi.org\/10.1007\/s40262-018-0636-7","journal-title":"Clin Pharmacokinet"},{"key":"2415_CR31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1046\/j.1365-2125.1999.00860.x","volume":"47","author":"JX Mazoit","year":"1999","unstructured":"Mazoit JX, Samii K. Binding of propofol to blood components: implications for pharmacokinetics and for pharmacodynamics. Br J Clin Pharmacol 1999; 47: 35\u201342. https:\/\/doi.org\/10.1046\/j.1365-2125.1999.00860.x","journal-title":"Br J Clin Pharmacol"},{"key":"2415_CR32","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1093\/bja\/aeu160","volume":"113","author":"TI Saari","year":"2014","unstructured":"Saari TI, Ihmsen H, Mell J, et al. Influence of intensive care treatment on the protein binding of sufentanil and hydromorphone during pain therapy in postoperative cardiac surgery patients. Br J Anaesth 2014; 113: 677\u201387. https:\/\/doi.org\/10.1093\/bja\/aeu160","journal-title":"Br J Anaesth"},{"key":"2415_CR33","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3390\/pharmaceutics14020445","volume":"14","author":"F Hefny","year":"2022","unstructured":"Hefny F, Stuart A, Kung JY, Mahmoud SH. Prevalence and risk factors of augmented renal clearance: a systematic review and meta-analysis. Pharmaceutics 2022; 14: 445. https:\/\/doi.org\/10.3390\/pharmaceutics14020445","journal-title":"Pharmaceutics"},{"key":"2415_CR34","doi-asserted-by":"publisher","first-page":"635","DOI":"10.2165\/00003088-200847100-00002","volume":"47","author":"B Blanchet","year":"2008","unstructured":"Blanchet B, Jullien V, Vinsonneau C, Tod M. Influence of burns on pharmacokinetics and pharmacodynamics of drugs used in the care of burn patients. Clin Pharmacokinet 2008; 47: 635\u201354. https:\/\/doi.org\/10.2165\/00003088-200847100-00002","journal-title":"Clin Pharmacokinet"},{"key":"2415_CR35","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.clinthera.2018.07.021","volume":"40","author":"AH Tse","year":"2018","unstructured":"Tse AH, Ling L, Lee A, Joynt GM. Altered pharmacokinetics in prolonged infusions of sedatives and analgesics among adult critically ill patients: a systematic review. Clin Ther 2018; 40: 1598\u2013615. https:\/\/doi.org\/10.1016\/j.clinthera.2018.07.021","journal-title":"Clin Ther"},{"key":"2415_CR36","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.2165\/11636220-000000000-00000","volume":"72","author":"DJ Roberts","year":"2012","unstructured":"Roberts DJ, Haroon B, Hall RI. Sedation for critically ill or injured adults in the intensive care unit: a shifting paradigm. Drugs 2012; 72: 1881\u2013916. https:\/\/doi.org\/10.2165\/11636220-000000000-00000","journal-title":"Drugs"},{"key":"2415_CR37","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1528-1157.1996.tb00021.x","volume":"37","author":"JT Backman","year":"1996","unstructured":"Backman JT, Olkkola KT, Ojala M, Laaksovirta H, Neuvonen PJ. Concentrations and effects of oral midazolam are greatly reduced in patients treated with carbamazepine or phenytoin. Epilepsia 1996; 37: 253\u20137. https:\/\/doi.org\/10.1111\/j.1528-1157.1996.tb00021.x","journal-title":"Epilepsia"},{"key":"2415_CR38","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00228-007-0398-x","volume":"64","author":"TI Saari","year":"2008","unstructured":"Saari TI, Laine K, Neuvonen M, Neuvonen PJ, Olkkola KT. Effect of voriconazole and fluconazole on the pharmacokinetics of intravenous fentanyl. Eur J Clin Pharmacol 2008; 64: 25\u201330. https:\/\/doi.org\/10.1007\/s00228-007-0398-x","journal-title":"Eur J Clin Pharmacol"},{"key":"2415_CR39","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1177\/10600280211010751","volume":"56","author":"D Dreucean","year":"2022","unstructured":"Dreucean D, Harris JE, Voore P, Donahue KR. Approach to Sedation and analgesia in COVID-19 patients on venovenous extracorporeal membrane oxygenation. Ann Pharmacother 2022; 56: 73\u201382. https:\/\/doi.org\/10.1177\/10600280211010751","journal-title":"Ann Pharmacother"},{"key":"2415_CR40","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1097\/mcc.0b013e3282f0a3d3","volume":"13","author":"M Schetz","year":"2007","unstructured":"Schetz M. Drug dosing in continuous renal replacement therapy: general rules. Curr Opin Crit Care 2007; 13: 645\u201351. https:\/\/doi.org\/10.1097\/mcc.0b013e3282f0a3d3","journal-title":"Curr Opin Crit Care"},{"key":"2415_CR41","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12882-016-0323-6","volume":"17","author":"R Claure-Del Granado","year":"2016","unstructured":"Claure-Del Granado R, Mehta RL. Fluid overload in the ICU: evaluation and management. BMC Nephrol 2016; 17: 109. https:\/\/doi.org\/10.1186\/s12882-016-0323-6","journal-title":"BMC Nephrol"},{"key":"2415_CR42","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1517\/17425255.2011.574127","volume":"7","author":"J Zhou","year":"2011","unstructured":"Zhou J, Poloyac SM. The effect of therapeutic hypothermia on drug metabolism and response: cellular mechanisms to organ function. Expert Opin Drug Metab Toxicol 2011; 7: 803\u201316. https:\/\/doi.org\/10.1517\/17425255.2011.574127","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2415_CR43","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1124\/dmd.109.031377","volume":"38","author":"D Hostler","year":"2010","unstructured":"Hostler D, Zhou J, Tortorici MA, et al. Mild hypothermia alters midazolam pharmacokinetics in normal healthy volunteers. Drug Metab Dispos 2010; 38: 781\u20138. https:\/\/doi.org\/10.1124\/dmd.109.031377","journal-title":"Drug Metab Dispos"},{"key":"2415_CR44","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s13181-017-0606-8","volume":"13","author":"MJ Neavyn","year":"2017","unstructured":"Neavyn MJ, Stolbach A, Greer DM, et al. ACMT position statement: determining brain death in adults after drug overdose. J Med Toxicol 2017; 13: 271\u20133. https:\/\/doi.org\/10.1007\/s13181-017-0606-8","journal-title":"J Med Toxicol"},{"key":"2415_CR45","doi-asserted-by":"publisher","unstructured":"Shemie SD, Lee D, Sharpe M, Tampieri D, Young B, Canadian Critical Care Society. Brain blood flow in the neurological determination of death: Canadian expert report. Can J Neurol Sci 2008; 35: 140\u20135. https:\/\/doi.org\/10.1017\/s0317167100008544","DOI":"10.1017\/s0317167100008544"}],"container-title":["Canadian Journal of Anesthesia\/Journal canadien d'anesth\u00e9sie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12630-023-02415-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12630-023-02415-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12630-023-02415-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T20:06:18Z","timestamp":1703621178000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12630-023-02415-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["2415"],"URL":"https:\/\/doi.org\/10.1007\/s12630-023-02415-4","relation":{},"ISSN":["0832-610X","1496-8975"],"issn-type":[{"value":"0832-610X","type":"print"},{"value":"1496-8975","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"29 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}